Patents by Inventor Stefan Höglund

Stefan Höglund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Random Access Comprising Sending or Receiving a MSG3 Message
    Publication number: 20240073960
    Abstract: Methods and apparatus are disclosed. In an example, a method performed by a wireless device for performing random access is disclosed. The method comprises transmitting a Msg3 message to a network node, wherein the Msg3 message includes an indication of whether the wireless device is a reduced capability wireless device.
    Type: Application
    Filed: January 13, 2022
    Publication date: February 29, 2024
    Inventors: Istiak Hossain, Andreas Höglund, Tuomas Tirronen, Stefan Wänstedt, Henrik Enbuske, Jan Christoffersson
  • Tripeptide amides that block viral infectivity and methods of use thereof
    Patent number: 6593455
    Abstract: Embodiments relate to the discovery that tripeptide amides, which correspond to viral capsid sequences, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising tripeptide amides and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: July 15, 2003
    Assignee: Tripep AB
    Inventors: David van der Spoel, Csaba Hetényi, Ákos Végvári, Stefan Höglund, Jin Su, Sarah Sandin-Reneby, Laura Goobar-Larsson, Anders Vahlne
  • Pentamer peptide amide, ALGPGNH2, which inhibits viral infectivity and methods of use thereof
    Patent number: 6537967
    Abstract: The present invention relates to the discovery that a specific pentamer peptide amide, which corresponds to a viral capsid sequence, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising said pentamer peptide amide and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.
    Type: Grant
    Filed: August 12, 2002
    Date of Patent: March 25, 2003
    Assignee: Tripep AB
    Inventors: David van der Spoel, Csaba Hetényi, Ákos Végvári, Stefan Höglund, Jin Su, Sarah Sandin-Reneby, Laura Goobar-Larsson, Anders Vahlne
  • Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
    Patent number: 6455670
    Abstract: The present invention relates to the discovery that a specific pentamer peptide amide, ALGPG-NH2, which corresponds to a viral capsid sequence, can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising said pentamer peptide amide and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.
    Type: Grant
    Filed: September 6, 2001
    Date of Patent: September 24, 2002
    Assignee: Tripep AB
    Inventors: David van der Spoel, Csaba Hetényi, Ákos Végvári, Stefan Höglund, Jin Su, Sarah Sandin-Reneby, Laura Goobar-Larsson, Anders Vahlne